Abstract | BACKGROUND: Wound healing problems and lymphoceles have been reported with greater frequency in kidney recipients given de novo sirolimus. This problem has led to increased patient morbidity and cost; and has been an impediment to the completion of randomized controlled trials in which wound problems have necessitated premature discontinuation of mammalian target of rapamycin inhibitors. METHODS: We developed a systematic program to reduce these problems based on patient selection (body mass index [BMI] <32 kg/m2), the use of closed suction drains, modifications of surgical technique, and avoidance of a loading dose of sirolimus. Consecutive series of adult kidney-only recipients given antibody induction followed by de novo sirolimus, mycophenolate mofetil, and steroids were compared; group 1: 204 patients transplanted with few restrictions and group 2: 103 patients transplanted using the above program. RESULTS: This approach resulted in a significant reduction (group 2 vs. group 1) in cumulative wound complications (7.8% vs. 19.6%, P=0.007), and nonoperative wound complications (2.9% vs. 14.2%, P=0.001). In addition, the incidence of lymphoceles detected (22.3% vs. 47.1%, P<0.0001), treated (4.8% vs. 24.5%, P<0.0001), or needing surgical intervention (1.9% vs. 14.2%, P=0.001) was significantly reduced. Multivariate analysis demonstrated that a BMI more than 30 to 32 kg/m2 was the most significant variable related to delayed wound healing (odds ratio [OR] 3.01, 0.02) or surgical repair (OR 8.05, P=0.0001), whereas BMI (OR 1.54, P=0.038) and acute rejections (OR 1.34, P=0.03) were most associated with lymphocele treatment. CONCLUSIONS: A systematic program of wound care using de novo sirolimus can produce wound healing complications comparable with that reported with other agents.
|
Authors | Ho Yee Tiong, Stuart M Flechner, Lingme Zhou, Alvin Wee, Barbara Mastroianni, Kathy Savas, David Goldfarb, Ithaar Derweesh, Charles Modlin |
Journal | Transplantation
(Transplantation)
Vol. 87
Issue 2
Pg. 296-302
(Jan 27 2009)
ISSN: 1534-6080 [Electronic] United States |
PMID | 19155988
(Publication Type: Journal Article)
|
Chemical References |
- Immunosuppressive Agents
- Steroids
- Mycophenolic Acid
- Sirolimus
|
Topics |
- Adult
- Body Mass Index
- Female
- Humans
- Immunosuppressive Agents
(adverse effects)
- Kidney Transplantation
(adverse effects)
- Lymphocele
(chemically induced, prevention & control)
- Male
- Middle Aged
- Mycophenolic Acid
(analogs & derivatives, therapeutic use)
- Odds Ratio
- Program Evaluation
- Proportional Hazards Models
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Sirolimus
(adverse effects)
- Steroids
(therapeutic use)
- Suction
- Wound Healing
(drug effects)
- Young Adult
|